Heart Transplantation in Human Immunodeficiency Virus-Positive Patients

Journal of Heart and Lung Transplantation

Volumn 28, Issue 7, 2009, Pages 667-669

  Uriel, Nir ^a   Jorde, Ulrich P ^a   Cotarlan, Vlad ^a   Colombo, Paolo C ^a   Farr, Maryjane ^a   Restaino, Susan W ^a   Lietz, Katherine ^a   Naka, Yoshifuma ^a   Deng, Mario C ^a   Mancini, Donna ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; DACLIZUMAB; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIAC GRAFT REJECTION; CD4 LYMPHOCYTE COUNT; CONGESTIVE CARDIOMYOPATHY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; SEROCONVERSION; TREATMENT INDICATION; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOMYOPATHY, DILATED; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67649134940     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.04.005     Document Type: Article

References (8)

1. Porter K., Babiker A., Bhaskaran K., et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 362 (2003) 1267-1274
2. Sackoff J.E., Hanna D.B., Pfeiffer M.R., and Torian L.V. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 145 (2006) 397-406
3. Calabrese L.H., Albrecht M., Young J., et al. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med 348 (2003) 2323-2328
4. Gupta S., Markham D.W., Mammen P.P., et al. Long-term follow-up of a heart transplant recipient with documented seroconversion to HIV-positive status 1 year after transplant. Am J Transplant 8 (2008) 893-896
5. Barbarinia G., and Barbaro G. Incidence of the involvement of the cardiovascular system in HIV infection. Aids 17 suppl 1 (2003) S46-S50
6. Jahangiri B., and Haddad H. Cardiac transplantation in HIV-positive patients: are we there yet?. J Heart Lung Transplant 26 (2007) 103-107
7. Bisleri G., Morgan J.A., Deng M.C., Mancini D.M., and Oz M.C. Should HIV-positive recipients undergo heart transplantation?. J Thorac Cardiovasc Surg 126 (2003) 1639-1640
8. Ciuffreda D., Pantaleo G., and Pascual M. Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation. Transpl Int 20 (2007) 649-658